Trial · NCT00407030
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Main Period - 8 to 20 Weeks | STARTED | incobotulinumtoxinA (Xeomin) (240 Units) | 81 | |
| Main Period - 8 to 20 Weeks | STARTED | incobotulinumtoxinA (Xeomin) (120 Units) | 78 | |
| Main Period - 8 to 20 Weeks | STARTED | Placebo | 74 | |
| Main Period - 8 to 20 Weeks | COMPLETED | incobotulinumtoxinA (Xeomin) (240 Units) | 76 | |
| Main Period - 8 to 20 Weeks | COMPLETED | incobotulinumtoxinA (Xeomin) (120 Units) | 75 | |
| Main Period - 8 to 20 Weeks | COMPLETED | Placebo | 68 | |
| Main Period - 8 to 20 Weeks | NOT COMPLETED | incobotulinumtoxinA (Xeomin) (240 Units) | 5 | |
| Main Period - 8 to 20 Weeks | NOT COMPLETED | incobotulinumtoxinA (Xeomin) (120 Units) | 3 | |
| Main Period - 8 to 20 Weeks | NOT COMPLETED | Placebo | 6 | |
| Extension Period - up to 68 Weeks | STARTED | incobotulinumtoxinA (Xeomin) (240 Units) | 111 | |
| Extension Period - up to 68 Weeks | STARTED | incobotulinumtoxinA (Xeomin) (120 Units) | 103 | |
| Extension Period - up to 68 Weeks | STARTED | Placebo | 0 | |
| Extension Period - up to 68 Weeks | COMPLETED | incobotulinumtoxinA (Xeomin) (240 Units) | 84 | |
| Extension Period - up to 68 Weeks | COMPLETED | incobotulinumtoxinA (Xeomin) (120 Units) | 74 | |
| Extension Period - up to 68 Weeks | COMPLETED | Placebo | 0 | |
| Extension Period - up to 68 Weeks | NOT COMPLETED | incobotulinumtoxinA (Xeomin) (240 Units) | 27 | |
| Extension Period - up to 68 Weeks | NOT COMPLETED | incobotulinumtoxinA (Xeomin) (120 Units) | 29 | |
| Extension Period - up to 68 Weeks | NOT COMPLETED | Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00407030/flow